cuprizone has been researched along with ginsenosides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, NH; Chu, SF; Dong, YX; Du, YS; He, WB; Tian, YJ; Wang, SS; Wang, ZZ; Yan, X; Zhang, Z | 1 |
| Chen, Y; Du, X; Guo, Y; Li, M; Li, Q; Li, Y; Liu, L; Liu, Q; Ran, Q; Sun, L; Yang, L; Yang, Q; Zhu, X | 1 |
2 other study(ies) available for cuprizone and ginsenosides
| Article | Year |
|---|---|
Rg1 exerts protective effect in CPZ-induced demyelination mouse model via inhibiting CXCL10-mediated glial response.
Topics: Animals; Chemokine CXCL10; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Ginsenosides; Hypokinesia; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Microglia; NF-kappa B; Panax; Phagocytosis; RNA, Small Interfering | 2022 |
Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
Topics: Animals; beta Catenin; Cell Differentiation; Cuprizone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Ginsenosides; Glycogen Synthase Kinase 3 beta; Mice; Mice, Inbred C57BL; Myelin Sheath; Oligodendrocyte Precursor Cells; Remyelination | 2022 |